Pfizer, Mylan Settle With Mass. AG Over EpiPen Commercial
Pfizer Inc. and Mylan Specialty LP agreed to pay a combined $625,000 to Massachusetts for running a TV commercial touting allergic reaction treatment EpiPen that allegedly ran afoul of an existing...To view the full article, register now.
Already a subscriber? Click here to view full article